FDA 483 - SNS Biosystems - June 24, 2022

SNS Biosystems, a Class II medical device manufacturer in Santa Maria, CA, was inspected by the FDA. The inspection revealed two significant issues: inadequate labeling examination, specifically regarding Unique Device Identifiers for spore strips, and a lack of documentation for equipment calibrations. These observations indicate deficiencies in quality system procedures.